| Literature DB >> 29552314 |
Borong Chen1, Disheng Xiong2, Zirong Pan3, Mingyuan Chen4, Gang Liu1, Shengjie Wang1, Yongzhi Ye1, Rui Xiao2, Junjie Zeng1, Jiayi Li5, Zhengjie Huang1,2.
Abstract
Totally laparoscopic distal gastrostomy (TLDG) and laparoscopic- assisted distal gastrostomy (LADG) are the minimally invasive surgical technology for gastric cancer. This study aimed to compare the surgical outcomes of these two methods. Relevant studies were selected through electronic searches of EMBASE, PubMed and Web of Science. In total, 21 non-randomized controlled studies containing 2475 patients in the totally laparoscopic distal gastrostomy and 1889 patients in the laparoscopic-assisted distal gastrostomy were included in this study. And operative time, operative blood loss, retrieved lymph nodes, time to liquid diet (days), postoperative hospital stay and overall complications were pooled and compared using meta-analysis. There were no significant differences between operative time (WMD = 0.38, 95% CI -10.43 -11.18, P = 0.95) and overall complications (RR = 1.09, 95% CI 0.91-1.30, P = 0.36). But totally laparoscopic distal gastrostomy had more advantages in aspects of intraoperative blood loss (WMD = 24.4, 95% CI 12.45-36.36, P < 0.0001), time to liquid diet (days) (WMD = 0.21, 95% CI 0.03-0.40, P = 0.03) and postoperative hospital stay (WMD = 0.72, 95% CI 0.31-1.13, P = 0.0006). Moreover, totally laparoscopic distal gastrostomy had more retrieved lymph nodes (WMD = -1.24, 95% CI-1.90 to-0.58, P = 0.0002). This meta-analysis indicates that totally laparoscopic distal gastrostomy may be a safe, feasible, and favorable surgical technology in terms of less blood loss, faster liquid diet, shorter postoperative hospital stay and more lymph nodes retrieved.Entities:
Keywords: gastric cancer; laparoscopic gastrostomy; meta-analysis
Year: 2018 PMID: 29552314 PMCID: PMC5844750 DOI: 10.18632/oncotarget.23895
Source DB: PubMed Journal: Oncotarget ISSN: 1949-2553
Figure 1Flow chart of the selecting process of literature
The characteristics of the included studies
| References | Country | Operation | Sex of patients | Age of patients | Level of | Reconstruction | |||
|---|---|---|---|---|---|---|---|---|---|
| LADG | TLDG | LADG | TLDG | LADG | TLDG | ||||
| Song (2008)8 | Korea | 20 | 20 | 12/8 | 13/7 | 58.5 ± 10.1 | 56.7 ± 13.5 | D1 + β, D2 | B-I, B-II, R-Y |
| Ikeda (2009) | Japan | 24 | 56 | 16/8 | 28/28 | 64.5 ± 11.9 | 63.5 ± 11.2 | D1 + β, D2 | B-I, R-Y |
| Kim MG (2010) | Korea | 328 | 239 | 198/130 | 155/84 | 55.4 ± 11.2 | 56.6 ± 12 | D2 | B-I |
| Kinoshita (2011) | Japan | 41 | 42 | 30/11 | 25/17 | 68.4 ± 10.3 | 64.7 ± 10 | D1 + α/β, D2 | B-I |
| Lee J (2012) | Korea | 269 | 130 | 161/108 | 75/54 | 62.5 ± 12.0 | 61.0 ± 11.8 | D1 + α/β, D2 | B-II |
| Choi (2013) | Korea | 35 | 37 | 22/13 | 23/14 | 67.9 ± 10.1 | 65.2 ± 10.9 | D1 + α/β, D2 | B-I, B-II, R-Y |
| Kim DG (2013) | Korea | 106 | 60 | 69/37 | 37/23 | 55.8 ± 12.5 | 58.3 ± 12.5 | D1 + β, D2 | B-I |
| Kim HG (2013) | Korea | 136 | 111 | 91/45 | 77/44 | 60.1 ± 11.7 | 61.0 ± 11.2 | D1 + β, D2 | B-I, B-II |
| Chen K (2014) | China | 93 | 147 | NR | NR | NR | NR | D2 | B-I, B-II |
| Han (2014) | Korea | 77 | 134 | 49/28 | 77/57 | 58.2 ± 10.4 | 57.2 ± 12.7 | D2 | B-II |
| Kanaji (2014) | Japan | 74 | 40 | 51/23 | 23/17 | 66 ± 9 | 63 ± 12 | D1 + α/β, D2 | B-I, B-II, R-Y |
| Lee SH (2015) | Korea | 99 | 33 | 58/41 | 20/13 | 58.8 ± 11.6 | 58.5 ± 12.2 | D1 + α/β, D2 | B-I, B-II, R-Y |
| Kim SM (2015) | Korea | 100 | 102 | 50/50 | 63/39 | 50 (32–75) | 52 (29–84) | D1 + β, D2 | B-I, B-II, R-Y |
| Woo (2015) | Korea | 55 | 55 | 37/18 | 35/20 | 59.0 ± 10.7 | 61.3 ± 11.9 | D2 | B-I, B-II, R-Y |
| Zhang B (2015) | China | 45 | 24 | 31/14 | 16/8 | NR | NR | D2 | B-I, B-II, R-Y |
| Zhang C (2015) | China | 25 | 11 | 7/4 | 16/9 | 62.24 ± 2.375 | 63.64 ± 2.516 | D1 + α/β, D2 | B-I, B-II, R-Y |
| Chen K (2016) | China | 145 | 108 | 98/47 | 73/35 | 57.3 ± 12.5 | 59.4 ± 11.1 | D1 + α/β, D2 | B-I, R-Y |
| Nishimura (2016) | Japan | 69 | 126 | 44/25 | 87/39 | 60.1 ± 11.7 | 61.0 ± 11.2 | D2 | B-I, B-II, R-Y |
| Shinohara (2016) | Japan | 43 | 57 | 25/18 | 36/21 | 72 (40–86) | 70 (38–80) | D1 + α/β, D2 | B-I, B-II, R-Y |
| Lin M (2016)-1 | China | 484 | 158 | 337/147 | 102/56 | 59.9 ± 11.7 | 59.0 ± 13.1 | D1 + α/β, D2 | B-I |
| Lin M (2016)-2 | China | 143 | 143 | 102/41 | 100/43 | 59.4 ± 12.1 | 60.1 ± 12.7 | D1 + α/β, D2 | B-I |
| Kim JH (2017) | Korea | 60 | 60 | 40/2 | 40/20 | 60.9 ± 11.4 | 60.5 ± 12.1 | D1 + α/β, D2 | B-I, B-II, R-Y |
TLDG: Totally laparoscopic distal gastrostomy; LADG: laparoscopic-assisted distal gastrostomy; B-I: Billroth I; B-II: Billroth II; R-Y: Roux-en-Y; NR: not reported.
Pooled short-term outcomes of meta-analysis
| Outcomes | Number of | Sample size | Heterogeneity | Overall | 95% CI of overall effect | ||
|---|---|---|---|---|---|---|---|
| LADG | TLDG | ||||||
| 20 | 2398 | 1811 | < 0.01, 96% | WMD = 0.38 | –10.43 to 11.18 | 0.95 | |
| 18 | 1001783 | < 0.01, 56% | WMD = 19.24 | 10.26 to 28.22 | < 0.01 | ||
| 14 | 13651032 | 0.13, 31% | WMD = –0.99 | –2.10 to 0.12 | 0.08 | ||
| 10 | 885717 | < 0.01, 95% | WMD = 0.27 | –0.07 to 0.61 | 0.11 | ||
| 11 | 915767 | < 0.01, 91% | WMD = 0.41 | 0.14 to 0.69 | < 0.01 | ||
| 19 | 2328 | 1734 | < 0.01, 78% | WMD = 0.72 | 0.31 to 1.13 | < 0.01 | |
| 13 | 14101077 | 0.78, 0% | WMD = 1.16 | 0.91 to 1.48 | 0.24 | ||
TLDG: Totally laparoscopic distal gastrostomy; LADG: laparoscopic-assisted distal gastrostomy; RR: risk ratio; WMD: weighted mean difference.
Figure 2Meta-analysis of the pooled data: operation time
Figure 3Meta-analysis of the pooled data: intraoperative blood loss
Figure 4Meta-analysis of the pooled data: retrieved lymph nodes
Figure 5Meta-analysis of the pooled data: time to liquid diet (days)
Figure 6Meta-analysis of the pooled data: postoperative hospital stay
Figure 7Meta-analysis of the pooled data: overall complications
Figure 8Funnel plots of the overall postoperative complications